Heath Lukatch insider trades

Open-market stock purchases and sales by Heath Lukatch, Director at Vaxcyte, Inc, from SEC Form 4 filings since Jun 17, 2015.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -87%.

Recent trades

DateStockTradeValue
Jun 15, 2026PCVX Vaxcyte, IncBought (not open market)—
Jun 15, 2026PCVX Vaxcyte, IncBought (not open market)—

Companies traded

  • PCVX Vaxcyte, Inc: 14 sales, last Jun 15, 2026
  • STSA Satsuma Pharmaceuticals, Inc: other filings, last Jun 8, 2023
  • FLXN Flexion Therapeutics Inc: other filings, last Nov 19, 2021
  • INGN Inogen Inc: 1 buy, 21 sales, last May 10, 2021

Get free alerts when Heath Lukatch files a new trade →